Brief: Agile Therapeutics Reports Q2 Loss Per Share $2.71
11/08/2022 22:35
Aug 11 (Reuters) - Agile Therapeutics Inc AGRX.O :
* AGILE THERAPEUTICS REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS
AND PROVIDES CORPORATE UPDATE
* Q2 LOSS PER SHARE $2.71
* CASH ON HAND EXPECTED TO FUND OPERATIONS THROUGH 2022
Source text for Eikon: ID:nGNX3V8lB
Further company coverage: AGRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Agile Therapeutics
See all newsBrief: Agile Therapeutics Inc. Announces Definitive Merger Agreement With Insud Pharma, S.L.
Agile Therapeutics Inc expected to post a loss of 92 cents a share - Earnings Preview
Brief: Agile Therapeutics Announces Delisting From Nasdaq
Agile Therapeutics Inc expected to post a loss of 54 cents a share - Earnings Preview
Brief: Agile Therapeutics Completes Pay-Off Of Debt